NCT00861367

Brief Summary

Aspirin is very common in older patients. Therefore many of the investigators patients have aspirin. The aim of the study is to proof that Transurethral Surgery of the bladder or the prostate can be performed with aspirin.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Sep 2008

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2008

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2009

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 12, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 13, 2009

Completed
Last Updated

March 19, 2024

Status Verified

March 1, 2024

Enrollment Period

4 months

First QC Date

March 12, 2009

Last Update Submit

March 18, 2024

Conditions

Keywords

aspirinblood losstransurethral surgery

Outcome Measures

Primary Outcomes (1)

  • Blood loss

    intraoperative, 6 hours post op, 3 days postop

Secondary Outcomes (1)

  • Reoperation rates

    during hospitalization

Study Arms (2)

1

ACTIVE COMPARATOR

aspirin 100mg

Drug: transurethral surgery with or without aspirin

2

PLACEBO COMPARATOR

empty capsule

Drug: transurethral surgery with or without aspirin

Interventions

aspirin 100mg once a day, transurethral surgery with or without aspirin

Also known as: Asprin cardio 100mg
12

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Transurethral surgery of the bladder or prostate, informed consent, age over 18

You may not qualify if:

  • Oral anticoagulation,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Urologische Universitätsklinik Basel-Liestal

Liestal, 4410, Switzerland

Location

MeSH Terms

Conditions

Blood Loss, SurgicalIntraoperative ComplicationsHemorrhage

Interventions

Aspirin

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

SalicylatesHydroxybenzoatesPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic Chemicals

Study Officials

  • Thomas C Gasser, Prof

    Department of Urology, Liestal

    STUDY CHAIR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 12, 2009

First Posted

March 13, 2009

Study Start

September 1, 2008

Primary Completion

January 1, 2009

Study Completion

January 1, 2009

Last Updated

March 19, 2024

Record last verified: 2024-03

Locations